Company Filing History:
Years Active: 2009
Title: Dilip Uttam Jadhav - A Pioneer in Pharmaceutical Innovation
Introduction
Dilip Uttam Jadhav, based in Mumbai, India, is an accomplished inventor known for his significant contributions to the field of pharmaceuticals. With a patent to his name, Jadhav has demonstrated his ability to innovate within the industry and contribute to advancements in drug synthesis.
Latest Patents
Jadhav's patent, titled "Process for manufacture of pure (2S, 3aS, 7aS)-1-[(2S)-2-[[(1S)-1-(ethoxycarbonyl) butyl]amino]-1-oxopropyl] octahydro-1H-indole-2-carboxylic acid and its tert. butyl amine salt," introduces new compounds that serve as synthetic intermediates for the synthesis of perindopril, a crucial pharmaceutical compound. Additionally, this invention outlines a new process for synthesizing perindopril and presents novel salts of the drug.
Career Highlights
Jadhav is associated with Ipca Laboratories Limited, a leading pharmaceutical company known for its quality and innovation. His work has been pivotal in developing effective methods for synthesizing important medical compounds, thereby improving drug availability for patients.
Collaborations
Throughout his career, Jadhav has collaborated with talented professionals such as Sanjay Tukaram Gunjal and Ashok Kumar. These partnerships have enhanced the development and refinement of his inventions, showcasing the importance of teamwork in the innovation process.
Conclusion
Dilip Uttam Jadhav is a notable figure in the pharmaceutical industry, with a clear focus on developing processes that improve the synthesis of essential drugs. His achievements in patenting a novel method for producing perindopril illustrate his dedication to innovation and highlight his significant contributions to medical science.